Anaesthetics - Local & General
| Drug | Dosage | Remarks |
|---|---|---|
| Lidocaine | Apply to affected area 6-8 hourly | Adverse Reactions
|
Analgesics (Non-Opioid)*
| Drug | Dosage | Remarks |
|---|---|---|
| Ibuprofen | 5-10 mg/kg PO 6-8 hourly Max dose: 40 mg/kg/day |
Adverse Reactions
|
| Paracetamol (Acetaminophen) |
10-15 mg/kg/dose PO/rectum 6-8 hourly or 2-12 years old (<33 kg): 75-300 mg IM 4-6 hourly >12 years old (>33 kg): 300-450 mg IM 4-6 hourly or >10 kg-<33 kg: 15 mg/kg slow IV 6 hourly Max dose: 2 g/day >33 kg-<50 kg: 15 mg/kg slow IV 6 hourly Max dose: 3 g/day >50 kg: 1 g slow IV 6 hourly Max dose: 4 g/day |
Adverse Reactions
|
| *Combination products are available. Please see the latest MIMS for specific formulations and prescribing information. | ||
Analgesics (Opioid)
| Drug | Dosage | Remarks |
|---|---|---|
| Methadone | 2.5 mg PO 8-12 hourly | Adverse Reactions
|
| Morphine | Acute pain: 0.1-0.2 mg/kg SC/IM 4-6 hourly or 0.05-0.1 mg/kg very slow IV Max dose: 15 mg/dose |
Adverse Reactions
|
| Nalbuphine | 0.1-0.2 mg/kg IM/IV/SC 3-6 hourly, as needed Max dose: 20 mg/dose or 160 mg/day |
Adverse Reactions
|
Emollients, Cleansers & Skin Protectives
| Drug | Available Strength and/or Preparations | Dosage | Remarks |
|---|---|---|---|
| Dexpanthenol | 2-5% cream, ointment, solution | Apply on affected area as needed | Special Instructions
|
| Petroleum jelly | 100% jelly | Apply thinly on affected area as needed | Special Instructions
|
| Zinc oxide | 7.5%, 10%, 15%, 18.5%, 32%, 310 mg/g cream; 3.8%, 7.5%, 10%, 20%, 40%, 200 mg/g ointment; paste; topical powder |
Apply on affected area 12-24 hourly | Special Instructions
|
Intravenous & Other Sterile Solutions
| Drug | Dosage | Remarks |
|---|---|---|
| Human albumin | 20-80 g/day (100-400 mL) IV infusion at 1 mL/min | Adverse Reactions
|
| Hydroxyethyl starch/NaCl | 10-20 mL slow IV infusion Dose and rate of maintenance/continuous infusion depends on the patient’s needs, hemodynamics and hydration status |
Adverse Reactions
|
| Plasma protein fraction (human) | 250-500 mL IV Adjust dose based on clinical response |
Adverse Reactions
|
| Polygeline | 20 mL/kg/day (500-1,500 mL) IV infusion Max dose: 2,000 mL |
Adverse Reactions
|
Other Dermatologicals*
| Drug | Dosage | Remarks |
|---|---|---|
| Boric acid | Apply to affected area 8-12 hourly | Special Instructions
|
| Hyaluronic acid | Apply to affected area 12 hourly or as needed | Special Instructions
|
| Polysiloxane | Apply to affected area 12-24 hourly | Special Instructions
|
| Silicone | Apply to affected area 12 hourly | Special Instructions
|
| Titrated extract of Centella asiatica (Centella asiatica extract) |
Apply to affected area 12-24 hourly | Adverse Reactions
|
| *Combination products are available. Please see the latest MIMS for specific formulations and prescribing information. | ||
Skin Antiseptics & Disinfectants
| Drug | Available Strength | Dosage | Remarks |
|---|---|---|---|
| Aloe vera | 87.4% gel | Apply to affected area every 30 minutes until burn pain disappears, then apply 8-12 hourly |
Adverse Reactions
|
| Cetrimide | 0.1%, 0.5% cream | Apply to affected area 8-12 hourly |
Adverse Reactions
|
| Chlorhexidine | 0.02%, 0.5%, 4%, 5% solution 1% cream |
Apply sufficient undiluted amount, rub until dry |
Special Instructions
|
| Feracrylum | 1% gel, solution | Apply to affected area directly or with gauze for 1-3 minutes until bleeding stops |
Special Instructions
|
| Povidone-iodine | Cream, ointment, solution, spray | Apply/spray to affected area 8 hourly May cover with dressing or bandage |
Adverse Reactions
|
| Triclosan/Allium cepa extract | 0.3% gel | Apply to affected area 8-12 hourly |
Adverse Reactions
|
Surgical Dressings & Wound Care
| Drug | Dosage | Remarks |
|---|---|---|
| Calcium alginate | Apply a single layer on the wound and cover with suitable dressing |
Adverse Reactions
|
| Chlorhexidine acetate | Apply directly on previously cleaned wound as dressing >1/day or 2x/week |
Special Instructions
|
| Collagen | Apply directly on sterilized wound May secure with gauze and adhesive plaster |
Adverse Reactions
|
| Framycetin | Apply directly on previously cleaned wound as dressing 24 hourly | |
| Fusidic acid (Fusidate, Na fusidate) |
||
| Hydrocolloid | Apply directly on previously cleaned wound as dressing |
Special Instructions
|
| Ionic silver/Na carboxymethyl-cellulose | Apply directly on sterilized wound Dressing should overlap 5 cm (2 inches) onto the skin surrounding the burn and should be covered with sterile gauze and secured in place |
Special Instructions
|
| Lyo acellular fish skin | Apply directly on previously cleaned wound May apply second non-adherent dressing to maintain a moist wound environment |
Special Instructions
|
| Melaleuca oil | Apply to burn area May bind lightly with bandage |
Special Instructions
|
| Nanocrystalline Ag | Moisten with sterile water then apply to affected area May apply second dressing to secure in place |
Adverse Reactions
|
| Octenidine diHCl | Apply single or double layer of dressing to wound and cover with secondary dressing |
Adverse Reactions
|
| Polyurethane1 | Apply on previously cleaned and dried wound |
Special Instructions
|
| Protein-free hemodialysate | Apply thinly 12-24 hourly and cover with dressing until wound has healed |
Adverse Reactions
|
| Recombinant human epidermal growth factor | Apply to wound 12 hourly |
Adverse Reactions
|
| Sodium hyaluronate | Gauze pad: Apply ≥1x/day Cream: Apply on affected area 8-12 hourly |
Adverse Reactions
|
| Zinc hyaluronate | Apply thinly on affected area |
Adverse Reactions
|
| 1Combination products are available. Please see the latest MIMS for specific formulations and prescribing information. | ||
Topical Antibiotics
| Drug | Dosage | Remarks |
|---|---|---|
| Amikacin | Apply on affected area 12-24 hourly |
Special Instructions
|
| Bacitracin | Apply on affected area 8-24 hourly |
Adverse Reactions
|
| Chloramphenicol | Apply on affected area 6-8 hourly |
Adverse Reactions
|
| Fusidic acid (Fusidate, Na Fusidate) |
Apply on affected area 8-12 hourly |
Adverse Reactions
|
| Gentamicin sulfate | Apply on affected area 6-8 hourly |
Adverse Reactions
|
| Mafenide | Apply a 16-mm layer on affected area 12-24 hourly |
Adverse Reactions
|
| Mupirocin | Apply on affected area 8 hourly |
Adverse Reactions
|
| Neomycin sulfate | Apply on affected area 8-12 hourly |
Adverse Reactions
|
| Nitrofurazone (Nitrofural) |
Apply on lesion or place first on gauze then apply on lesion |
Adverse Reactions
|
| Oxytetracycline | Apply on affected area 8-12 hourly |
Adverse Reactions
|
| Tetracycline | Apply on affected area 12-24 hourly |
Special Instructions
|
| Silver sulfadiazine | Apply 2-3 mm on affected area 24 hourly |
Adverse Reactions
|
| Sulfasomidine | Apply thin layer over affected area |
Adverse Reactions
|
Topical Antihistamines/Antipruritics
| Drug | Dosage | Remarks |
|---|---|---|
| Pramoxine HCl | Apply to affected area 6-8 hourly | Adverse Reactions
|
Topical Corticosteroids
| Drug | Dosage | Remarks |
|---|---|---|
| Desoximetasone | Apply to affected area 8-24 hourly | Adverse Reactions
|
Vaccines, Antisera & Immunologicals
| Drug | Dosage | Remarks |
|---|---|---|
| Immunoglobulin | ||
| Human tetanus immunoglobulin |
250 IU IM for 1 dose May increase to 500 IU IM Extensive burns: Administer second injection of 250 IU IM after exudative phase of burn (>36 hours after onset of burn) |
Adverse Reactions
|
| Vaccine | ||
| Tetanus toxoid (Tetanus toxoid, adsorbed) |
Clean Minor Wound Not/partially immunized: 0.5 mL/dose for 1 dose >10 years since last booster dose with complete immunization: 0.5 mL/dose for 1 dose Clean Major/Tetanus-Prone Wound Not/partially immunized: 0.5 mL/dose for 1 dose* 5-10 years since last booster dose with complete immunization: 0.5 mL/dose for 1 dose >10 years since last booster dose with complete immunization: 0.5 mL/dose for 1 dose* Tetanus-Prone/Delayed/Incomplete Debridement Not/partially immunized: 0.5 mL/dose for 1 dose** 5-10 years since last booster dose with complete immunization: 0.5 mL/dose for 1 dose >10 years since last booster dose with complete immunization: 0.5 mL/dose for 1 dose** |
Adverse Reactions
|
|
*Given with Human tetanus immunoglobulin 250 IU in the other arm. **Given with Human tetanus immunoglobulin 500 IU in the other arm and antibiotics. |
||
Disclaimer
All dosage recommendations are for non-pregnant and non-breastfeeding women, and non-elderly adults with normal renal and hepatic function unless otherwise stated.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
